Avera Institute for Human Genetics
The Avera Institute for Human Genetics (AIHG) is a state-of-the-art molecular genetics laboratory with the capability to undertake a wide range of projects from small-scale pilot candidate gene projects to large-scale high throughput genome-wide association studies on tens of thousands of samples.
Advancing science through numerous partnerships that have been established both nationally and internationally, AIHG is poised to translate this knowledge to the bedside to improve the care provided to our patients and the communities served by Avera.
AIHG has expanded its research on personalizing medicine, the process of customizing health care or medical treatment specific to an individual’s needs.
Pharmacogenomics, the study of how an individual’s genetic make-up affects how that individual will respond to medications, is one of the most important components of personalized medicine and provides physicians a tool to help them make predictions on drug effectiveness, optimal dose and potential adverse reactions, individualized to the patient. Current personalized medicine projects utilize pharmacogenomics for pain management, medication effectiveness, and ADHD treatment.
The AIHG scientific lab houses cutting-edge genetics laboratory equipment enabling researchers to describe a patient's genetic profile, for example, the iScan Beadchip Array platform and Next Generation Sequencers from Illumina plus a QuantStudio and Viia7 Real-Time PCR Systems from Thermo Fisher Scientific.